MAP2K2 and ductal breast carcinoma in situ: Two targetable oncogenic pathways that were found to be upregulated between the preneoplastic and DCIS states are : the MEK and pAKT-S6 pathways (MEK2 and S6_pS235_S236) (Fig. S2B).